CoChat

Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer

Open access
He, Liang, Zhang, Siliang, Zhang, Xiaowen, Liu, Rui, Guan, Haixia, Zhang, Hao · 2017 · OncoTargets and Therapy

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

PURPOSE: This study was aimed to investigate the expressions of the insulin receptor (IR), insulin-like growth factor receptor (IGF-1R), and glucagon-like peptide-1 receptor (GLP-1R) in normal thyroid tissue, papillary thyroid cancer (PTC) tissues, and PTC cells, and to examine the possible role of insulin analogs and GLP-1R agonists in cell proliferation and energy metabolism in PTC cells. METHODS: The expressions of IR, IGF-1R, and GLP-1R in PTC tissues and PTC cell lines were detected by immunohistochemistry and western blotting, respectively. Cell proliferation was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Levels of members of the phosphoinositol-3 kinase/AKT serine/threonine kinase (Akt) and mitogen-activated protein kinase/extracellular signal-regulated kinase (Erk) signaling pathways were measured by western blotting. Energy metabolism of PTC cell lines was analyzed using a Seahorse Extracellular Flux analyzer. RESULTS: Three receptors could be detected in both PTC tissues and PTC cell lines. Expressions of IGF-1R and GLP-1R were more obvious in PTC than in normal thyroid cells. Neither insulin, four insulin analogs, and two GLP-1R agonists showed significant effects on the proliferation of PTC cells, nor did they influence the levels of Akt/p-Akt and Erk/p-Erk. None of these antidiabetic agents could change the mitochondrial respiration and glycolysis levels in PTC cell lines. CONCLUSION: Both PTC tissues and the PTC cell lines express IR, IGF-1R, and GLP-1R. However, insulin analogs and GLP-1R agonists, which are commonly used to treat patients with diabetes, may not influence cell proliferation, the phosphoinositol-3 kinase/Akt and mitogen-activated protein kinase/Erk pathways, or energy metabolism in PTC cells. For now, it is not necessary to avoid use of these antidiabetic agents in patients with PTC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ott.s150701

Cites

Statistics

Figures

Figure 1 Expressions of IR, IGF-1R, and GLP-1R in human thyroid tissues and cells. Notes: (A) IR, IGF-1R, and GLP-1R IHC (×200) of PTC and normal tissues. (B) Expression of IR, IGF-1R, and GLP-1R in primary cultured thyrocytes and PTC cell lines. Scale bar =100 μm. Abbreviations: GLP-1R, glucagon-like peptide-1 receptor; IGF-1R, insulin-like growth factor receptor; IHC, immunohistochemistry; IR, insulin receptor; PTC, papillary thyroid cancer.
Figure 1 Expressions of IR, IGF-1R, and GLP-1R in human thyroid tissues and cells. Notes: (A) IR, IGF-1R, and GLP-1R IHC (×200) of PTC and normal tissues. (B) Expression of IR, IGF-1R, and GLP-1R in primary cultured thyrocytes and PTC cell lines. Scale bar =100 μm. Abbreviations: GLP-1R, glucagon-like peptide-1 receptor; IGF-1R, insulin-like growth factor receptor; IHC, immunohistochemistry; IR, insulin receptor; PTC, papillary thyroid cancer.CC BY-NC · PubMed Central
Figure 2 Effects of regular insulin and insulin analogs on the proliferation of PTC cell lines. Notes: Results from MTT assays at 48 h after the treatment. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; IHH4, human papillary thyroid carcinoma cell line; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.
Figure 2 Effects of regular insulin and insulin analogs on the proliferation of PTC cell lines. Notes: Results from MTT assays at 48 h after the treatment. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; IHH4, human papillary thyroid carcinoma cell line; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.CC BY-NC · PubMed Central
Figure 3 Effects of regular insulin and insulin analogs on PI3K/Akt and MAPK/Erk signaling pathways in PTC cell lines. Notes: PTC cells were treated with insulin or each insulin analog at 1,500 nmol/L for 48 h. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: Akt, AKT serine/threonine kinase; BCPAP, normal human thyroid cells; Erk, extracellular signal-regulated kinase; IHH4, human papillary thyroid carcinoma cell line; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositol-3 kinase; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.
Figure 3 Effects of regular insulin and insulin analogs on PI3K/Akt and MAPK/Erk signaling pathways in PTC cell lines. Notes: PTC cells were treated with insulin or each insulin analog at 1,500 nmol/L for 48 h. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: Akt, AKT serine/threonine kinase; BCPAP, normal human thyroid cells; Erk, extracellular signal-regulated kinase; IHH4, human papillary thyroid carcinoma cell line; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositol-3 kinase; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.CC BY-NC · PubMed Central
Figure 4 Effects of regular insulin and insulin analogs on mitochondrial respiration and glycolysis in PTC cell lines. Notes: PTC cells were treated with insulin or each insulin analog at 1,500 nmol/L for 48 h. Oligomycin (1 μM), FCCP (0.25 μM), rotenone (1 μM), and antimycin A (1 μM) were delivered at indicated times to determine different parameters of mitochondrial functions; glucose (10 mM), oligomycin (1.0 μM), and 2-deoxy-D-glucose (100 mM) were delivered at indicated times to determine different parameters of glycolysis status. These drugs were added according to the manufacturer’s protocols. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; ECAR, extracellular acidification rate; FCCP, p-trifluoromethoxyphenylhydrazone; IHH4, human papillary thyroid carcinoma cell line; OCR, oxygen consumption rate; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.
Figure 4 Effects of regular insulin and insulin analogs on mitochondrial respiration and glycolysis in PTC cell lines. Notes: PTC cells were treated with insulin or each insulin analog at 1,500 nmol/L for 48 h. Oligomycin (1 μM), FCCP (0.25 μM), rotenone (1 μM), and antimycin A (1 μM) were delivered at indicated times to determine different parameters of mitochondrial functions; glucose (10 mM), oligomycin (1.0 μM), and 2-deoxy-D-glucose (100 mM) were delivered at indicated times to determine different parameters of glycolysis status. These drugs were added according to the manufacturer’s protocols. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; ECAR, extracellular acidification rate; FCCP, p-trifluoromethoxyphenylhydrazone; IHH4, human papillary thyroid carcinoma cell line; OCR, oxygen consumption rate; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.CC BY-NC · PubMed Central
Figure 5 Effects of GLP-1R agonists on the proliferation of PTC cell lines. Notes: Results from MTT assays at 24, 48, and 72 h after the treatment. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; GLP-1R, glucagon-like peptide-1 receptor; IHH4, human papillary thyroid carcinoma cell line; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.
Figure 5 Effects of GLP-1R agonists on the proliferation of PTC cell lines. Notes: Results from MTT assays at 24, 48, and 72 h after the treatment. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; GLP-1R, glucagon-like peptide-1 receptor; IHH4, human papillary thyroid carcinoma cell line; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.CC BY-NC · PubMed Central
Figure 6 Effects of GLP-1R agonists on PI3K/Akt and MAPK/Erk signaling pathways in PTC cell lines. Notes: PTC cells were treated with liraglutide or exenatide (100 nmol/L) for 48 h. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: Akt, AKT serine/threonine kinase; BCPAP, normal human thyroid cells; Erk, extracellular signal-regulated kinase; GLP-1R, glucagon-like peptide-1 receptor; IHH4, human papillary thyroid carcinoma cell line; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositol-3 kinase; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.
Figure 6 Effects of GLP-1R agonists on PI3K/Akt and MAPK/Erk signaling pathways in PTC cell lines. Notes: PTC cells were treated with liraglutide or exenatide (100 nmol/L) for 48 h. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: Akt, AKT serine/threonine kinase; BCPAP, normal human thyroid cells; Erk, extracellular signal-regulated kinase; GLP-1R, glucagon-like peptide-1 receptor; IHH4, human papillary thyroid carcinoma cell line; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositol-3 kinase; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.CC BY-NC · PubMed Central
Figure 7 Effects of GLP-1R agonists on mitochondrial respiration and glycolysis in PTC cell lines. Notes: PTC cells were treated with liraglutide or exenatide (100 nmol/L) for 48 h. Oligomycin (1 μM), FCCP (0.25 μM), rotenone (1 μM), and antimycin A (1 μM) were delivered at the indicated times to determine different parameters of mitochondrial functions; glucose (10 mM), oligomycin (1.0 μM), and 2-deoxy-D-glucose (100 mM) were delivered at indicated times to determine different parameters of glycolysis status. These drugs were added according to the manufacturer’s protocols. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; ECAR, extracellular acidification rate; FCCP, p-trifluoromethoxyphenylhydrazone; GLP-1R, glucagon-like peptide-1 receptor; IHH4, human papillary thyroid carcinoma cell line; OCR, oxygen consumption rate; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.
Figure 7 Effects of GLP-1R agonists on mitochondrial respiration and glycolysis in PTC cell lines. Notes: PTC cells were treated with liraglutide or exenatide (100 nmol/L) for 48 h. Oligomycin (1 μM), FCCP (0.25 μM), rotenone (1 μM), and antimycin A (1 μM) were delivered at the indicated times to determine different parameters of mitochondrial functions; glucose (10 mM), oligomycin (1.0 μM), and 2-deoxy-D-glucose (100 mM) were delivered at indicated times to determine different parameters of glycolysis status. These drugs were added according to the manufacturer’s protocols. (A) IHH4, (B) BCPAP, and (C) TPC-1. Abbreviations: BCPAP, normal human thyroid cells; ECAR, extracellular acidification rate; FCCP, p-trifluoromethoxyphenylhydrazone; GLP-1R, glucagon-like peptide-1 receptor; IHH4, human papillary thyroid carcinoma cell line; OCR, oxygen consumption rate; PTC, papillary thyroid cancer; TPC-1, human thyroid cancer cell line.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 40 · Cited by 40

Metadata

Authors
He, L., Zhang, S., Zhang, X., Liu, R., Guan, H., & Zhang, H.
Affiliations
  • First Hospital of China Medical University (CN)
  • Nanjing Drum Tower Hospital (CN)
Corresponding author
  • Guan, Haixia
  • Zhang, Hao
Venue
OncoTargets and Therapy
Published
2017-11
Volume
Volume 10
Pages
5621-5631
ISSN
1178-6930 (ISSN-L)
OpenAlex
W2770957382
Cited by
40
References
40
Citations by year
2026: 6 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1
FWCI
0.86
Type
journal article
Language
en
Open access
Locations
  • OncoTargets and Therapy (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
Chinese Medical Association
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
papillary thyroid carcinoma, insulin analogues, GLP-1 receptor agonists, insulin receptor, IGF-1 receptor, GLP-1 receptor, cell proliferation, cellular energy metabolism, Akt signaling, ERK signaling, antidiabetic drugs, mitochondrial respiration, glycolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer. https://app.cochat.ai/papers/10.2147/ott.s150701
The paper
He, L., Zhang, S., Zhang, X., Liu, R., Guan, H., & Zhang, H. (2017). Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer. OncoTargets and Therapy. https://doi.org/10.2147/ott.s150701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.